Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

NCT04495088 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

550

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: mFOLFOX (neoadjuvant)
DRUG: XELOX (neoadjuvant)
DRUG: mFOLFOX (adjuvant)
DRUG: XELOX (adjuvant)
DRUG: Capecitabine (adjuvant)
DRUG: infusional 5-FU/FA "AIO" regimen (adjuvant)
DRUG: infusional 5-FU/FA "de Gramont" (adjuvant)

Sponsor

Ralf Hofheinz

Collaborators

[object Object]
[object Object]
[object Object]